Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01226472 · ClinicalTrials.gov registry record · Phase 2
Extension Study in Subjects Who Relapsed After Complete Response on Study KW-0761-001
A Phase 2 study, sponsored by Kyowa Kirin Co..
- Completed
- Registry status
- Phase 2
- Development phase
- 1
- Enrollment target
NCT01226472 is a Phase 2 study that has completed, run by Kyowa Kirin Co.. The registered enrollment target is 1 participants.
The verdict
NCT01226472, a Phase 2 study, has completed, sponsored by Kyowa Kirin Co..
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 1 participants
- Enrollment target
Study Summary
This study will enroll subjects with either Peripheral T-Cell Lymphoma (PTCL) or Cutaneous T-Cell Lymphoma(CTCL),including mycosis fungoides (MF) and Sezary Syndrome (SS), who have relapsed after achieving a complete response in study, KW-0761-001.
Interventions
- BIOLOGICAL KW-0761
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2010-08 |
| Est. Completion | 2012-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01226472
The ClinicalTrials.gov registry entry for NCT01226472 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kyowa Kirin Co., which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which KW-0761 is the first listed.
NCT01226472 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01226472 about?
NCT01226472 is a clinical study titled "Extension Study in Subjects Who Relapsed After Complete Response on Study KW-0761-001". This study will enroll subjects with either Peripheral T-Cell Lymphoma (PTCL) or Cutaneous T-Cell Lymphoma(CTCL),including mycosis fungoides (MF) and Sezary Syndrome (SS), who have relapsed after achieving a complete response in study, KW-0761-001.
What is the current status of trial NCT01226472?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 1 participants. The study started on 2010-08. Estimated completion is 2012-09.
What interventions are being tested in trial NCT01226472?
The interventions under investigation include: KW-0761 (BIOLOGICAL).
Who is sponsoring clinical trial NCT01226472?
This trial is sponsored by Kyowa Kirin Co., which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.